BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8695268)

  • 1. Multidrug resistance reversal in childhood malignancies--potential for a real step forward?
    Pinkerton CR
    Eur J Cancer; 1996 Apr; 32A(4):641-4. PubMed ID: 8695268
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological considerations in the modulation of multidrug resistance.
    Fisher GA; Lum BL; Hausdorff J; Sikic BI
    Eur J Cancer; 1996 Jun; 32A(6):1082-8. PubMed ID: 8763350
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of the P-glycoprotein, the multidrug transporter.
    Stein WD
    Exp Physiol; 1998 Mar; 83(2):221-32. PubMed ID: 9568482
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis and reversal of multidrug resistance in paediatric cancers.
    Chan HS; Grogan TM; DeBoer G; Haddad G; Gallie BL; Ling V
    Eur J Cancer; 1996 Jun; 32A(6):1051-61. PubMed ID: 8763347
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers.
    Ford JM
    Eur J Cancer; 1996 Jun; 32A(6):991-1001. PubMed ID: 8763340
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance.
    Twentyman PR; Versantvoort CH
    Eur J Cancer; 1996 Jun; 32A(6):1002-9. PubMed ID: 8763341
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal of multidrug resistance in acute myeloid leukaemia and other haematological malignancies.
    Sonneveld P
    Eur J Cancer; 1996 Jun; 32A(6):1062-9. PubMed ID: 8763348
    [No Abstract]   [Full Text] [Related]  

  • 8. Biology of the multidrug resistance-associated protein, MRP.
    Loe DW; Deeley RG; Cole SP
    Eur J Cancer; 1996 Jun; 32A(6):945-57. PubMed ID: 8763335
    [No Abstract]   [Full Text] [Related]  

  • 9. Transporter molecules in multidrug resistance.
    Scheper RJ; Scheffer GL; Flens MJ; van der Valk P; Broxterman HJ; Izquierdo MA
    Cytotechnology; 1996; 19(3):187-90. PubMed ID: 8862005
    [No Abstract]   [Full Text] [Related]  

  • 10. Multidrug resistance: genes, polymorphisms, biologic effects, reversal and treatment in cancer chemotherapy.
    Aragon-Ching JB
    Anticancer Agents Med Chem; 2010 Oct; 10(8):582. PubMed ID: 21244347
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidrug resistance: can new drugs help chemotherapy score against cancer?
    Goldman B
    J Natl Cancer Inst; 2003 Feb; 95(4):255-7. PubMed ID: 12591977
    [No Abstract]   [Full Text] [Related]  

  • 12. P-glycoprotein mediated multidrug resistance and its implications for pathology.
    Trambas CM; Muller HK; Woods GM
    Pathology; 1997 May; 29(2):122-30. PubMed ID: 9213329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein--a mediator of multidrug resistance in tumour cells.
    Germann UA
    Eur J Cancer; 1996 Jun; 32A(6):927-44. PubMed ID: 8763334
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.
    Krishna R; Mayer LD
    Eur J Pharm Sci; 2000 Oct; 11(4):265-83. PubMed ID: 11033070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical reversal of multidrug resistance.
    Sikic BI; Fisher GA; Lum BL; Brophy NA; Yahanda AM; Adler KM; Halsey J
    Cancer Treat Res; 1994; 73():149-65. PubMed ID: 7710904
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular mechanisms of drug resistance in single-step and multi-step drug-selected cancer cells.
    Calcagno AM; Ambudkar SV
    Methods Mol Biol; 2010; 596():77-93. PubMed ID: 19949921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance in pediatric oncology.
    Kuttesch JF
    Invest New Drugs; 1996; 14(1):55-67. PubMed ID: 8880394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of multidrug resistance.
    Sonneveld P; Wiemer E
    Curr Opin Oncol; 1997 Nov; 9(6):543-8. PubMed ID: 9370075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ABC transporters in clinical practice.
    Leonard GD; Fojo T; Bates SE
    Oncologist; 2003; 8(5):411-24. PubMed ID: 14530494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: How does the MRP/GS-X pump export doxorubicin?
    Broxterman HJ; Heijn M; Lankelma J
    J Natl Cancer Inst; 1996 Apr; 88(7):466-8. PubMed ID: 8618244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.